Nitric Oxide Prevents H2O2-Induced Apoptosis in SK-N-MC Human Neuroblastoma Cells Yeong-Min Yoo, Eui-Man Jung, Changhwan Ahn, Eui-Bae Jeung

Total Page:16

File Type:pdf, Size:1020Kb

Nitric Oxide Prevents H2O2-Induced Apoptosis in SK-N-MC Human Neuroblastoma Cells Yeong-Min Yoo, Eui-Man Jung, Changhwan Ahn, Eui-Bae Jeung Int. J. Biol. Sci. 2018, Vol. 14 1974 Ivyspring International Publisher International Journal of Biological Sciences 2018; 14(14): 1974-1984. doi: 10.7150/ijbs.28050 Research Paper Nitric oxide prevents H2O2-induced apoptosis in SK-N-MC human neuroblastoma cells Yeong-Min Yoo, Eui-Man Jung, Changhwan Ahn, Eui-Bae Jeung Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, Republic of Korea Corresponding author: Eui-Bae Jeung, PhD. Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 28644, Republic of Korea. E-mail: [email protected] © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2018.06.22; Accepted: 2018.09.04; Published: 2018.11.02 Abstract Nitric oxide (NO) is a cellular signaling molecule in many physiological and pathological processes including neuroprotector. Here we examined the antiapoptotic effect of NO in SK-N-MC cells. H2O2 treatment (10-200 μM) induced cell death in a dose-dependent manner and pretreatment of cells with 100 μM S-nitroso-N-acetylpenicillamine (SNAP), an NO donor, attenuated the occurrence of H2O2-induced cell death. DAPI staining showed H2O2-induced nuclear fragmentation and NO treatment suppressed it. NO inhibited the proteolytic activation of caspase-3 and mitochondrial cytochrome c release. Treatment of soluble guanylyl cyclase inhibitor ODQ decreased the protective effect of SNAP on H2O2-treated cells and increased caspase 3-like enzyme activity and activation, cytochrome c release, PARP cleavage, and DNA fragmentation, indicating that cGMP is a key mediator in NO-mediated antiapoptosis. The cGMP analog 8-Br-cGMP blocked H2O2-induced apoptotic cell death; reduction of caspase-3 enzyme, cytochrome c release, and caspase-8 and -9. These preventive effects of SNAP and 8-Br-cGMP were suppressed by PKG inhibitor KT5823. Levels of PKGI, PKGII, and p-VASP proteins were increased by SNAP and 8-Br-cGMP and suppressed by KT5823 treatment. These results indicate that PKG is a downstream signal mediator in the suppression of apoptosis by NO and cGMP. Akt activation was inhibited the PI3K inhibitors LY294002 and Wortmannin, resulting in the inhibition of cell viability and increase of cytochrome c release. SNAP induced phosphorylation of Akt and Bad and then increased the interactions between 14-3-3β and p-Bad. These data suggest that the NO suppresses H2O2-induced SK-N-MC cell apoptosis by suppressing apoptosis signal mediating the interaction between 14‐3‐3β and Bad phosphorylation via PKG/PI3K/Akt. Key words: Nitric oxide; hydrogen peroxide; PKG; PI3K; Akt Introduction Hydrogen peroxide (H2O2) has been known as a produced by the conversion of L-arginine to signaling molecule in various biological processes L-citrulline, a reaction catalyzed by one of three NO including cell proliferation, differentiation, migration, synthases (NOS): neuronal NOS (nNOS), endothelial autophagy, and apoptosis [1-4]. These molecules can NOS (eNOS), and inducible NOS (iNOS) [8, 9]. NO decompose into a hydroxyl radical through Fenton has been shown as a tissue-protection through its reaction or Haber-Weiss reaction [5]. Hydroxyl physiologic regulation of vascular tone, inhibition of radicals can react with and damage vital cellular platelet aggregation, attenuation of leukocyte components, especially the mitochondria. At last cells adherence to the endothelium, scavenging of or tissues induces cell death, or accelerates aging and oxygen-derived free radicals, maintenance of normal cancer [6, 7]. vascular permeability, inhibition of smooth muscle Nitric oxide (NO) has been known to be proliferation, immune defenses, and stimulation of http://www.ijbs.com Int. J. Biol. Sci. 2018, Vol. 14 1975 endothelial cell regeneration [9]. Furthermore, NO is established in 1971 from the supraorbital metastatic to be a mediator/protector of ischemia and site in a 14-year-old Caucasian female with an Askin’s reperfusion tissue-mediated injury [9] and tumor related to Ewing's sarcoma. The SK-N-MC cells neuroprotector in neurodegenerative diseases show little or no dopamine-beta-hydroxylase activity including Parkinson’s disease (PD), Alzheimer’s but increase choline acetyltransferase activity disease (AD), Huntington’s disease (HD), and compared to other neuroblastoma cell lines such as amyotrophic lateral sclerosis (ALS) [8]. the SK-N-SH, SK-N-BE, and SH-SY5Y. Therefore, in In PC12 cells, NO protects against serum the present study, the NO suppresses H2O2-induced withdrawal-cell death by inhibiting the activation of human neuroblastoma SK-N-MC cell apoptosis by caspase through cGMP production and activation of suppressing apoptosis signal through activating protein kinase G (PKG) [10]. Also, this molecule PKG/PI3K/Akt and result in the increase of the suppresses 6-hydroxydopamine (6-OHDA)-induced interaction between 14‐3‐3β and Bad phosphorylation. apoptosis by activating PKG via phosphatidylinositol-3 kinase (PI3K)/Akt-dependent Results Bad phosphorylation [11]. In the primary neurons, The protection of NO against H2O2-induced NO-activated survival signaling involves nerve apoptosis in SK-N-MC cells growth factor (NGF)-like effects, including enhanced We investigated the protection of NO against phosphorylation of TrkA and activation of PI3K/Akt H2O2-induced apoptosis in human neuroblastoma and MAPK pathways [12]. Andoh et al. [13] reported SK-N-MC cells. H2O2 treatment (10-200 μM) induced that the cytoprotective effect of NO in human cell death in a dose-dependent manner and neuroblastoma SH-SY5Y cells appears to proceed via pretreatment of cells with 100 μM SNAP, an NO the PKG-mediated pathway and the expression of donor, attenuated the occurrence of H2O2-induced cell thioredoxin and thioredoxin peroxidase-1. Ciani et al. death; viabilities of cells treated with SNAP were [14] showed that NO protection in serum about 90, 83, 75, 70, and 52%, respectively, of the starved-SK-N-BE neuroblastoma cell apoptosis is control value (100%) (Figure 1A). DAPI staining associated with cAMP-response element-binding showed H2O2-induced nuclear fragmentation and NO protein (CREB) activation. The SK-N-MC cells are a treatment suppressed it (Figure 1B). human neuroblastoma cell line. This cell line was Figure 1. Protective effect of SNAP against the H2O2-induced death of SK-N-MC cells. The SK-N-MC cells were cultured in DMEM supplemented with 10% heat-inactivated FBS at 37°C in 5% CO2, 95% air in a humidified cell incubator. Cells were treated with H2O2 for 24 hr, and SNAP was added 10 hr prior to H2O2 treatment. Cell viability assay was performed by Cell Counting Kit-8 (A). DAPI staining was analyzed by fluorescence microscopy (B). Values were represented as mean ± SD from three independent experiments. Scale bar, 50 μm. **P < 0.01, ***P < 0.01 versus no treatment of SNAP. #p < 0.01, ##p < 0.01, ###p < 0.001 versus 100 μM SNAP treatment. +++p < 0.001, no treatment of 100 μM SNAP versus 100 μM SNAP treatment. http://www.ijbs.com Int. J. Biol. Sci. 2018, Vol. 14 1976 Figure 2. Protective effect of SNAP and caspase inhibitors on the survival of SK-N-MC cells. The SK-N-MC cells were cultured in DMEM supplemented with 10% heat-inactivated FBS at 37°C in 5% CO2, 95% air in a humidified cell incubator. Cells were treated with H2O2 for 24 hr, and SNAP was added 10 hr prior to H2O2 treatment. Cells were treated with SNAP (100 μM), Ac-YVAD-cho (200 μM), or Ac-DEVD-cho (200 μM) in media. At 24 hr, cell viability was determined by Cell Counting Kit-8 (A). SK-N-MC cells were collected, washed with ice-cold PBS, and lysed in 100 mM HEPES buffer, pH 7.4, containing protease inhibitors. Caspase-3 enzyme activity was determined by measuring the absorbance of the fraction at 405 nm, with 200 μM Ac-DEVD-pNA as a substrate for caspase-3 enzyme (B). Western blot analyses of caspase-3 activation and cytochrome c (C) were determined as described in Materials and methods. Values were represented as mean ± SD from three independent experiments. ***p < 0.01 versus nontreatment of SNAP. ###p < 0.001, 100 μM H2O2 treatment versus 100 μM SNAP/H2O2 or Ac-DEVD-cho/H2O2 treatment. The effect of SNAP and inhibitors of caspase Ac-DEVD-cho, respectively, but not by the addition of on SK-N-MC cell apoptosis Ac-YVAD-cho (Figure 2C). These results indicate that the NO on H2O2-treated SK-N-MC cells may inhibit We examined the effect of SNAP and inhibitors by an inhibition of caspase 3-like enzyme activation of caspase on SK-N-MC cell apoptosis and caspase and/or activity. 3-like activity. The caspase-3-like protease inhibitor Ac-DEVD-cho prevented H2O2-induced cell death, The role of cGMP in NO-mediated protection whereas the caspase-1-like protease inhibitor To determine the role of cGMP in NO-mediated Ac-YVAD-cho did not (Figure 2A). The protective protection, the effects of SNAP on SK-N-MC cells effect of Ac-DEVD-cho was comparable with the were examined in the presence of an inhibitor of effect of SNAP (100 μM) treatment. Caspase-3-like soluble guanylyl cyclase ODQ (Figure 3). ODQ did enzyme activity was measured in the cytosol from not affect the cell viability of cells but inhibited the H2O2-treated cells by a colorimetric assay using protective effect of SNAP on H2O2-treated cells substrate-specific tetrapeptides (Figure 2B). (Figure 3A). Also, treatment with ODQ prevented the Caspase-3-like enzyme activity in H2O2-treated cell capacity of SNAP to decrease caspase-3-like enzyme extracts was about 6-fold higher than that of untreated activity (Figure 3B) and to identify caspase-3 control cells.
Recommended publications
  • Use of Computational Biochemistry for Elucidating Molecular Mechanisms of Nitric Oxide Synthase
    Use of Computational Biochemistry for Elucidating Molecular Mechanisms of Nitric Oxide Synthase Bignon, Emmanuelle; Rizza, Salvatore; Filomeni, Giuseppe; Papaleo, Elena Published in: Computational and Structural Biotechnology Journal DOI: 10.1016/j.csbj.2019.03.011 Publication date: 2019 Document version Publisher's PDF, also known as Version of record Citation for published version (APA): Bignon, E., Rizza, S., Filomeni, G., & Papaleo, E. (2019). Use of Computational Biochemistry for Elucidating Molecular Mechanisms of Nitric Oxide Synthase. Computational and Structural Biotechnology Journal, 17, 415- 429. https://doi.org/10.1016/j.csbj.2019.03.011 Download date: 02. Oct. 2021 Computational and Structural Biotechnology Journal 17 (2019) 415–429 Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/csbj Mini Review Use of Computational Biochemistry for Elucidating Molecular Mechanisms of Nitric Oxide Synthase Emmanuelle Bignon a,⁎, Salvatore Rizza b, Giuseppe Filomeni b,c, Elena Papaleo a,d,⁎⁎ a Computational Biology Laboratory, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen, Denmark b Redox Signaling and Oxidative Stress Group, Cell Stress and Survival Unit, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen, Denmark c Department of Biology, University of Rome Tor Vergata, Rome, Italy d Translational Disease Systems Biology, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research University of Copenhagen, Copenhagen, Denmark article info abstract Article history: Nitric oxide (NO) is an essential signaling molecule in the regulation of multiple cellular processes. It is endoge- Received 21 December 2018 nously synthesized by NO synthase (NOS) as the product of L-arginine oxidation to L-citrulline, requiring NADPH, Received in revised form 17 March 2019 molecular oxygen, and a pterin cofactor.
    [Show full text]
  • Soluble Guanylate Cyclase B1-Subunit Expression Is Increased in Mononuclear Cells from Patients with Erectile Dysfunction
    International Journal of Impotence Research (2006) 18, 432–437 & 2006 Nature Publishing Group All rights reserved 0955-9930/06 $30.00 www.nature.com/ijir ORIGINAL ARTICLE Soluble guanylate cyclase b1-subunit expression is increased in mononuclear cells from patients with erectile dysfunction PJ Mateos-Ca´ceres1, J Garcia-Cardoso2, L Lapuente1, JJ Zamorano-Leo´n1, D Sacrista´n1, TP de Prada1, J Calahorra2, C Macaya1, R Vela-Navarrete2 and AJ Lo´pez-Farre´1 1Cardiovascular Research Unit, Cardiovascular Institute, Hospital Clı´nico San Carlos, Madrid, Spain and 2Urology Department, Fundacio´n Jime´nez Diaz, Madrid, Spain The aim was to determine in circulating mononuclear cells from patients with erectile dysfunction (ED), the level of expression of endothelial nitric oxide synthase (eNOS), soluble guanylate cyclase (sGC) b1-subunit and phosphodiesterase type-V (PDE-V). Peripheral mononuclear cells from nine patients with ED of vascular origin and nine patients with ED of neurological origin were obtained. Fourteen age-matched volunteers with normal erectile function were used as control. Reduction in eNOS protein was observed in the mononuclear cells from patients with ED of vascular origin but not in those from neurological origin. Although sGC b1-subunit expression was increased in mononuclear cells from patients with ED, the sGC activity was reduced. However, only the patients with ED of vascular origin showed an increased expression of PDE-V. This work shows for the first time that, independently of the aetiology of ED, the expression of sGC b1-subunit was increased in circulating mononuclear cells; however, the expression of both eNOS and PDE-V was only modified in the circulating mononuclear cells from patients with ED of vascular origin.
    [Show full text]
  • Effects of Tetrahydrobiopterin on Endothelial Dysfunction in Rats with Ischemic Acute Renal Failure
    J Am Soc Nephrol 11: 301–309, 2000 Effects of Tetrahydrobiopterin on Endothelial Dysfunction in Rats with Ischemic Acute Renal Failure MASAO KAKOKI,* YASUNOBU HIRATA,* HIROSHI HAYAKAWA,* ETSU SUZUKI,* DAISUKE NAGATA,* AKIHIRO TOJO,* HIROAKI NISHIMATSU,* NOBUO NAKANISHI,‡ YOSHIYUKI HATTORI,§ KAZUYA KIKUCHI,† TETSUO NAGANO,† and MASAO OMATA* *The Second Department of Internal Medicine, Faculty of Medicine, and †Faculty of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan; ‡Department of Biochemistry, Meikai University School of Dentistry, Saitama, Japan; and §Department of Endocrinology, Dokkyo University School of Medicine, Tochigi, Japan. Abstract. The role of nitric oxide (NO) in ischemic renal injury 4 fmol/min per g kidney; serum creatinine: control 23 Ϯ 2, is still controversial. NO release was measured in rat kidneys ischemia 150 Ϯ 27, ischemia ϩ BH4 48 Ϯ 6 ␮M; mean Ϯ subjected to ischemia and reperfusion to determine whether SEM). Most of renal NOS activity was calcium-dependent, and (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4), a cofactor of NO its activity decreased in the ischemic kidney. However, it was synthase (NOS), reduces ischemic injury. Twenty-four hours restored by BH4 (control 5.0 Ϯ 0.9, ischemia 2.2 Ϯ 0.4, after bilateral renal arterial clamp for 45 min, acetylcholine- ischemia ϩ BH4 4.3 Ϯ 1.2 pmol/min per mg protein). Immu- induced vasorelaxation and NO release were reduced and renal noblot after low-temperature sodium dodecyl sulfate-polyac- excretory function was impaired in Wistar rats. Administration rylamide gel electrophoresis revealed that the dimeric form of of BH4 (20 mg/kg, by mouth) before clamping resulted in a endothelial NOS decreased in the ischemic kidney and that it marked improvement of those parameters (10Ϫ8 M acetylcho- was restored by BH4.
    [Show full text]
  • Nitric Oxide Synthase Inhibitors As Antidepressants
    Pharmaceuticals 2010, 3, 273-299; doi:10.3390/ph3010273 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review Nitric Oxide Synthase Inhibitors as Antidepressants Gregers Wegener 1,* and Vallo Volke 2 1 Centre for Psychiatric Research, University of Aarhus, Skovagervej 2, DK-8240 Risskov, Denmark 2 Department of Physiology, University of Tartu, Ravila 19, EE-70111 Tartu, Estonia; E-Mail: [email protected] (V.V.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +4577893524; Fax: +4577893549. Received: 10 November 2009; in revised form: 7 January 2010 / Accepted: 19 January 2010 / Published: 20 January 2010 Abstract: Affective and anxiety disorders are widely distributed disorders with severe social and economic effects. Evidence is emphatic that effective treatment helps to restore function and quality of life. Due to the action of most modern antidepressant drugs, serotonergic mechanisms have traditionally been suggested to play major roles in the pathophysiology of mood and stress-related disorders. However, a few clinical and several pre-clinical studies, strongly suggest involvement of the nitric oxide (NO) signaling pathway in these disorders. Moreover, several of the conventional neurotransmitters, including serotonin, glutamate and GABA, are intimately regulated by NO, and distinct classes of antidepressants have been found to modulate the hippocampal NO level in vivo. The NO system is therefore a potential target for antidepressant and anxiolytic drug action in acute therapy as well as in prophylaxis. This paper reviews the effect of drugs modulating NO synthesis in anxiety and depression. Keywords: nitric oxide; antidepressants; psychiatry; depression; anxiety 1. Introduction Recent data from Denmark and Europe [1,2], indicate that brain disorders account for 12% of all direct costs in the Danish health system and 9% of the total drug consumption was used for treatment of brain diseases.
    [Show full text]
  • Nitric Oxide Synthase Inhibitors
    Chapter 12 Nitric Oxide Synthase Inhibitors Elizabeth Igne Ferreira and Ricardo Augusto Massarico Serafim Additional information is available at the end of the chapter http://dx.doi.org/10.5772/67027 Abstract Nitric oxide (NO) is an endogenic product from plants, bacteria, and animal cells that has many important effects in those organisms. It is produced by nitric oxide synthase (NOS), which is found in main three isoforms, namely endothelial NOS (eNOS), induc- ible NOS (iNOS), and neuronal NOS (nNOS). It has an important role in homeostasis in different physiological systems, such as micro- and macro-vascularization, inhibition of platelet aggregation, and neurotransmission regulation in the central nervous, gastroin- testinal, respiratory, and genitourinary systems. However, its overproduction has been associated with diseases such as arthritis, asthma, cerebral ischemia, Parkinson’s disease, neurodegeneration, and seizures. For this reason, and due to better understanding of the molecular mechanisms by which NO provokes those diseases, the interest on the design of NOS inhibitors with therapeutic purposes has highly increased. Based on the forego - ing considerations, the proposal of this chapter is to show an overview about the design strategies, mechanism of action at the molecular level, and the main advances toward the search for selective NOS inhibitors available in the literature. Keywords: nitric oxide synthase isoforms, structure-based drug design, enzymatic inhibition, selectivity, heterocyclic compounds 1. Introduction Nitric oxide (NO) is a diatomic neutral molecule, produced by bacteria, plants, and animals. Having one unpaired electron, its effect in biological system is related to the stabilization of this electron. It acts as dissolved nonelectrolyte in the organisms, except for the lungs, where it is found in gaseous state [1–3].
    [Show full text]
  • Modulation of Retinal Dopaminergic Cells by Nitric Oxide. a Protective Effect on NMDA-Induced Retinal Injury
    in vivo 18: 311-316 (2004) Review Modulation of Retinal Dopaminergic Cells by Nitric Oxide. A Protective Effect on NMDA-induced Retinal Injury YASUSHI KITAOKA1 and TOSHIO KUMAI2 Departments of 1Ophthalmology and 2Pharmacology, St Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan Abstract. Nitric oxide (NO) may play an important role in experimental glaucoma (7). Thus, the involvement of regulating retinal neuronal survival. While the precise impact of elevated vitreal glutamate in glaucoma is not well NO mechanisms on retinal neurons remains to be elucidated, it established. Nonetheless, an understanding of the has been reported that low doses of NO may have a biochemical mechanism by which glutamate regulates neuroprotective effect against N-methyl-D-aspartate (NMDA)- retinal neuronal survival is important in developing induced retinal neurotoxicity. Dopamine has also been therapeutics for protecting retinal neuronal cells at the recognized to have neuroprotective actions. Retinal dopaminergic injured site in several ocular disorders including glaucoma, cells can be detected by the immunohistochemical staining of ischemia (8,9) and optic neuropathy (10,11). tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis. We observed that NMDA dramatically decreased in TH NMDA-induced neurotoxicity immunostaining at the junction between the inner nuclear layer and inner plexiform layer, and that this reduction in The excitotoxic effect of glutamate on the retinal neuronal immunostaining was attenuated by the co-injection of NOC 18, cells has been well demonstrated. Among the several an NO donor. Thus, the current review focused on the NO- glutamate receptors, activation of the N-methyl-D-aspartate dopamine interactions in the retinal neuroprotection.
    [Show full text]
  • 2-Thiouracil Is a Selective Inhibitor of Neuronal Nitric Oxide Synthase Antagonising Tetrahydrobiopterin-Dependent Enzyme Activation and Dimerisation
    FEBS 24297 FEBS Letters 485 (2000) 109^112 2-Thiouracil is a selective inhibitor of neuronal nitric oxide synthase antagonising tetrahydrobiopterin-dependent enzyme activation and dimerisation Anna Palumboa;*, Marco d'Ischiab, Fernando A. Cio¤c aZoological Station `Anton Dohrn', Villa Comunale, 80121 Naples, Italy bDepartment of Organic Chemistry and Biochemistry, University of Naples Federico II, Via Cinthia, 80134 Naples, Italy cDepartment of Neurosurgery, Second University of Naples, Viale Colli Aminei 21, 80100 Naples, Italy Received 11 October 2000; accepted 14 October 2000 First published online 6 November 2000 Edited by Barry Halliwell these enzymes in biological systems [6]. The research and clin- Abstract 2-Thiouracil (TU), an established antithyroid drug and melanoma-seeker, was found to selectively inhibit neuronal ical utility of this approach is well apparent in the case of neurological conditions, especially ischaemia/reperfusion and nitric oxide synthase (nNOS) in a competitive manner (Ki =20 WM), being inactive on the other NOS isoforms. The drug vasospasm secondary to subarachnoid haemorrhage, where apparently interfered with the substrate- and tetrahydrobiopterin recognition of the pathophysiological role of nNOS has war- (BH4)-binding to the enzyme. It caused a 60% inhibition of ranted considerable interest toward novel selective inhibitors H2O2 production in the absence of L-arginine and BH4, and of this isoform [7]. antagonised BH4-induced dimerisation of nNOS, but did not Functionally active nNOS is homodimeric and each subunit affect cytochrome c reduction. These results open new perspec- contains a reductase domain that binds NADPH, FAD and tives in the understanding of the antithyroid action of TU and FMN, and an oxygenase domain, that binds haem, the sub- provide a new lead structure for the development of selective strate L-arginine and tetrahydrobiopterin (BH ) [2,3].
    [Show full text]
  • Increased Arginase II Activity Contributes to Endothelial Dysfunction Through Endothelial Nitric Oxide Synthase Uncoupling in Aged Mice
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 44, No. 10, 594-602, October 2012 Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice Woosung Shin1, Dan E. Berkowitz2,3 ArgII. These results might be associated with and Sungwoo Ryoo1,4 increased L-arginine bioavailability. Collectively, these results suggest that ArgII may be a valuable 1Department of Biology target in age-dependent vascular diseases. College of Natural Sciences Kangwon National University Keywords: aging; arginase II; endothelial nitric oxide Chuncheon 200-701, Korea synthase uncoupling; small interfering RNA; vascular 2Department of Anesthesiology and Critical Care Medicine diseases 3Department of Biomedical Engineering Johns Hopkins Medical Institutions Baltimore, MD 21287, USA Introduction 4Corresponding author: Tel, 82-33-250-8534; Fax, 82-33-251-3990; E-mail, [email protected] Cardiovascular disease is the leading cause of http://dx.doi.org/10.3858/emm.2012.44.10.068 morbidity and mortality in both industrialized and developing countries. Despite effective treatments Accepted 27 July 2012 for several established cardiovascular risk factors, Available Online 2 August 2012 such as hypertension and hypercholesterolemia, the incidence of cardiovascular disease is predicted Abbreviations: ABH, 2 (S)-amino-6-boronohexanoic acid; Ach, to increases as the population ages. Characteristic acetylcholine; Arg I, arginase I; ArgII, arginase II; DAF, 4-amino- events in the aging cardiovascular system include 5-methylamino-2', 7'-difluorescein; DHE, dihydroethidium; L-arg, vascular stiffness (Meaume et al., 2001), enhanced G L-arginine; L-NAME, L-N -nitroarginine methyl ester; MnTBAP, Mn reactive oxygen species (ROS) production (Finkel (III)tetrakis (4-benzoic acid) porphyrin chloride; ns, not significant; and Holbrook, 2000; Brandes et al., 2005), and ROS, reactive oxygen species; siArgII, siRNA to arginase II decreased nitric oxide (NO) bioavailability (Adler et al., 2003; Csiszar et al., 2008).
    [Show full text]
  • Novel Nitric Oxide Signaling Mechanisms Regulate the Erectile Response
    International Journal of Impotence Research (2004) 16, S15–S19 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $30.00 www.nature.com/ijir Novel nitric oxide signaling mechanisms regulate the erectile response AL Burnett Department of Urology, The Johns Hopkins Hospital, Baltimore, Maryland, USA Nitric oxide (NO) is a physiologic signal essential to penile erection, and disorders that reduce NO synthesis or release in the erectile tissue are commonly associated with erectile dysfunction. NO synthase (NOS) catalyzes production of NO from L-arginine. While both constitutively expressed neuronal NOS (nNOS) and endothelial NOS (eNOS) isoforms mediate penile erection, nNOS is widely perceived to predominate in this role. Demonstration that blood-flow-dependent generation of NO involves phosphorylative activation of penile eNOS challenges conventional understanding of NO-dependent erectile mechanisms. Regulation of erectile function may not be mediated exclusively by neurally derived NO: Blood-flow-induced fluid shear stress in the penile vasculature stimulates phosphatidyl-inositol 3-kinase to phosphorylate protein kinase B, which in turn phosphorylates eNOS to generate NO. Thus, nNOS may initiate cavernosal tissue relaxation, while activated eNOS may facilitate attainment and maintenance of full erection. International Journal of Impotence Research (2004) 16, S15–S19. doi:10.1038/sj.ijir.3901209 Keywords: 1-phosphatidylinositol 3-kinase; penile erection; nitric-oxide synthase; endothelium Introduction synthesizes NO. In this brief review, the relatively new science of constitutive NOS activation via protein kinase phosphorylation is discussed, with The discovery of nitric oxide (NO) as a major particular attention given to its role in penile molecular regulator of penile erection about a erection and to its possible therapeutic relevance decade ago has had a profound impact on the field for ED.
    [Show full text]
  • Chronic Hypoxia Increases Inducible NOS-Derived Nitric Oxide in Fetal Guinea Pig Hearts
    0031-3998/09/6502-0188 Vol. 65, No. 2, 2009 PEDIATRIC RESEARCH Printed in U.S.A. Copyright © 2009 International Pediatric Research Foundation, Inc. Chronic Hypoxia Increases Inducible NOS-Derived Nitric Oxide in Fetal Guinea Pig Hearts LOREN THOMPSON, YAFENG DONG, AND LASHAUNA EVANS Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland 21201 ABSTRACT: Intrauterine hypoxia impacts fetal growth and organ ible NOS (iNOS)͔, all of which are expressed in the heart function. Inducible nitric oxide synthase (iNOS) and neuronal NOS (10,11). Specifically, eNOS is expressed constitutively in both (nNOS) expression was measured to assess the response of fetal endothelial cells and cardiomyocytes (10), nNOS in both hearts to hypoxic (HPX) stress. Pregnant guinea pigs were housed in cardiomyocytes and conducting tissue of cardiac ventricles a hypoxic chamber (10.5% O for 14 d, n ϭ 17) or room air 2 (12), and iNOS in cardiomyocytes (12) and in mature hearts [normoxic (NMX), n ϭ 17͔. Hearts of anesthetized near-term fetuses under conditions of hypoxia (12–14), heart failure (15), left were removed. mRNA ͓hypoxia-inducible factor, (HIF)-1␣,1␤,2␣, 3␣, iNOS, and nNOS͔ and protein levels (HIF-1␣, iNOS, and nNOS) ventricular hypertrophy (16) and cardiac cyanosis in children of fetal cardiac left ventricles were quantified by real time polymer- (17). NOS gene expression has been reported to be oxygen- ase chain reaction (PCR) and Western analysis, respectively. Cardiac sensitive, with levels varying among cardiac cells (18,19) and nitrite/nitrate levels were measured in the presence/absence of L-N6- endothelial cells of differing vascular origin (20–22).
    [Show full text]
  • International Journal of Impotence Research (1999) 11, Suppl 1, S65±S72 1 2
    International Journal of Impotence Research (1999) 11, Suppl 1, S65±S72 1 2 DOES CHANGE IN CARDIOVASCLL\R RISK FACTORS SERUM ANDROGENS :\ND ERECTILE DYSFUNCTION: PREVENT ERECTILE DYSFUNCTIO'.\? Carol A. Derby, Beth LONGITUDINAL DATA I R0\1 THI \:IASSACHUSETTS A. Mohr, Irwin Goldstein, Henry A. Feldman, Catherine B. MALE AGING STUDY. lknrv A. Idd1nan*, Christopher Johannes, John B. McKinlay (New Engbnd Research Institutes, Longcopet, and John B. I\IcKinlay' 1*Ncw England Research Watertown, MA 02742, USA). Inst., Watertown MA; tliniv ..\1a,s. \frd. Ctr., Worcester MA). Erectile dysfunction (ED) increases in prevalence with age, Although modifiable risk factors for erectile dysfunction (ED) but its relation to the slow decline in serum testosterone or other have been identified, little is known regarding prevention. We hormones controlling sexual function is uncertain, despite prospectively examined the association of changes in smoking reports of amelioration hy supplemental testosterone. In the (yes/ no), heavy alcohol use (>3 drinks /day), sedentary lifestyle Massachusetts Male Aging Study, a large population-hascd (< 200 kcal/day of moderate to intense activity) and obesity (BMI random sample of men aged 40-70 were twice interviewed at 2 2: 30 kg/m ) to incident ED in the randomly selected cohort of the home, in 1987-89 and 1995-97, on each occasion providing Massachusetts Male Aging Study. Of 1709 men aged 40-70 in comprehensive health information. blood samples, and a 1987-1989, analyses included 593 with follow-up in 1995-1997 privately completed sexual ,1c1i,itv LJUcstionnaire. We analyzed who were free of ED at baseline, had no history of prostate a subsample of 634 men vv hu had minimal or no ED at baseline cancer, and were not treated for heart disease or diabetes.
    [Show full text]
  • Nitric Oxide Therapy for Dermatologic Disease
    SPECIAL FOCUS y Nitric oxide-releasing materials Special Report For reprint orders, please contact [email protected] 0 Special Report2015/05/05 Nitric oxide therapy for dermatologic disease Brandon L Adler1 Future Sci. OA Nitric oxide (NO) plays an important role in the maintenance and regulation of the skin and the integrity of its environment. Derangement of NO production is implicated in & Adam J Friedman*,1,2,3 1 the etiology of a multitude of dermatologic diseases, indicating future therapeutic Department of Medicine (Division of Dermatology), Albert Einstein College of directions. In an era of increasing resistance rates to available antibiotics and subpar Medicine, Bronx, NY, USA development of new agents, NO is promising as a prospective topical broad-spectrum 2Department of Physiology & Biophysics, 1(1), FSO37 antimicrobial agent with small likelihood of resistance development. Because the Albert Einstein College of Medicine, greatest strides have been made in the setting of infectious disease and skin and soft- Bronx, NY, USA 3 tissue infection, this will be a major focus of this article. In addition, we will review George Washington School of Medicine & Health Sciences, Washington, DC, USA NO’s role in skin regulation and dysregulation, immune function, the various topical *Author for correspondence: release systems that have been devised and tested, NO’s relation to UV radiation and [email protected] skin pigmentation, and finally, its potential applications as a cosmeceutical. Nitric oxide (NO) is a molecule that plays many roles in both normal and abnormal skin processes. There is strong evidence that NO-releasing materials may serve as new, unique antimicrobial agents, at a juncture when current antibiotics are confounded by increasingly resistant microorganisms.
    [Show full text]